Approval of BRINSUPRI™ for the Treatment of Non-Cystic Fibrosis Bronchiectasis

Today’s Highlights August 13, 2025

Insmed Incorporated
Today, investors must have realized the upward movement prices of the Viking Therapeutics (VKTX) and Intellia Therapeutics (NTLA . . .

This content is for paid subscribers.

Please click here to subscribe or here to log in.

Today’s Highlights
Broadcom Inc (AVGO), Insmed Incorporated (INSM), Intellia Therapeutics (NTLA), Nvidia Corporation (NVDA), Viking Therapeutics (VKTX)
August 13, 2025

Tweet Pin It

Other Articles

Precigen Announces Full FDA Approval of PAPZIMEOS, the Only Currently Approved Treatment for Adults with Recurrent Respiratory Papillomatosis

August 15, 2025 0

How Alnylam Pharmaceuticals Made Our Day Today and More

July 31, 2025 0

GSK Announces the Linked by Lupus: Optimal Care Initiative to Help Support Individuals with Lupus in the US

July 28, 2025 0

AstraZeneca’s Product Gefurulimab Demonstrated Daily Living of Adults with Generalised Myasthenia Gravis in PREVAIL Phase III Trial

July 24, 2025 0

Search ProhostBiotech

Popular Links
Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) CytomX Therapeutics Inc (CTMX) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Neurocrine Biosciences (NBIX) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)

Recent

ProhostBiotech Archive
ProhostBiotech Archive
Sign Up for Weekly Emails
First Name

Last Name

Email address:

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Exclusive Market Insight

& Scientific analysis

Approval of BRINSUPRI™ for the Treatment of Non-Cystic Fibrosis Bronchiectasis